Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aleglitazar in type 2 diabetes with recent acute coronary syndrome
CTR20140137Phase 3Suspended
- Sponsor
- Roche
- Start
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of aleglitazar in type 2 diabetes mellitus (T2DM), acute coronary syndrome (ACS), sponsored by Roche. Started Oct 2014; status: suspended.
02
Drugs
aleglitazar
03
Conditions
type 2 diabetes mellitus (T2DM)acute coronary syndrome (ACS)
Beyond the preview
Go deeper on CTR20140137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140137.